Fred B. Craves, Ph.D.
Board Member
Madrigal Pharmaceuticals, Inc. (MDGL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Fred B. Craves, Ph.D.
Fred B. Craves, Ph.D. is recorded as Board Member at Madrigal Pharmaceuticals, Inc. (MDGL). Madrigal Pharmaceuticals, Inc. reported in an 8-K filed March 11, 2025 that Fred B. Craves, Ph.D. resigned as Board of Directors, effective July 1, 2025. Madrigal Pharmaceuticals, Inc. reported in an 8-K filed June 27, 2024 that Fred B. Craves, Ph.D. was appointed Class II Nominee, effective June 25, 2024.
“On March 9, 2025, Fred Craves, Ph.D. provided notice of his resignation from the Board of Directors (the "Board") of Madrigal Pharmaceuticals, Inc. (the "Company"), effective as of July 1, 2025.”
“The Company's stockholders elected each of the three Class II nominees named below to serve on the Company's Board of Directors for a three-year term expiring at the Company's 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-25–present
-
2024-06-25–2025-07-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Madrigal Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Bill Sibold CEO, Board Member
- Julian C. Baker Chairman, Board Member
- Mardi Dier CFO
- Brian J. Lynch General Counsel
- Rita Thakkar Chief Accounting Officer
- Daniel J. Brennan Board Member
- Jacqualyn A. Fouse Board Member
- Jacqualyn Fouse, Ph.D. Board Member
- James M. Daly Board Member
- John C. Reed Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.